Continuous versus discrete frequency changes: different detection mechanisms?

J Acoust Soc Am

Laboratoire Mouvement, Adaptation, Cognition UMR CNRS 5227, Universite de Bordeaux, Bordeaux, France.

Published: February 2009


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Sek and Moore [J. Acoust. Soc. Am. 106, 351-359 (1999)] and Lyzenga et al. [J. Acoust. Soc. Am. 116, 491-501 (2004)] found that the just-noticeable frequency difference between two pure tones relatively close in time is smaller when these tones are smoothly connected by a frequency glide than when they are separated by a silent interval. This "glide effect" was interpreted as evidence that frequency glides can be detected by a specific auditory mechanism, not involved in the detection of discrete, time-delayed frequency changes. Lyzenga et al. argued in addition that the glide-detection mechanism provides little information on the direction of frequency changes near their detection threshold. The first experiment reported here confirms the existence of the glide effect, but also shows that it disappears when the glide is not connected smoothly to the neighboring steady tones. A second experiment demonstrates that the direction of a 750 ms frequency glide can be perceptually identified as soon as the glide is detectable. These results, and some other observations, lead to a new interpretation of the glide effect, and to the conclusion that continuous frequency changes may be detected in the same manner as discrete frequency changes.

Download full-text PDF

Source
http://dx.doi.org/10.1121/1.3050271DOI Listing

Publication Analysis

Top Keywords

frequency changes
20
frequency
9
discrete frequency
8
changes detection
8
acoust soc
8
frequency glide
8
glide
6
changes
5
continuous versus
4
versus discrete
4

Similar Publications

Unlabelled: Crimes against the sexual integrity of the individual represent one of the most serious forms of violence.

Objective: To perform a retrospective epidemiological analysis with the systematization of analytical data on the performed forensic medical examinations (FMEs) of survivors of sexual abuse in order to increase the effectiveness of the system of preventive measures against such crimes.

Material And Methods: The data from the industry statistical report №42 were analyzed.

View Article and Find Full Text PDF

BackgroundAlzheimer's disease (AD) is the most common neurodegenerative disorder. While AD diagnosis traditionally relies on clinical criteria, recent trends favor a precise biological definition. Existing biomarkers efficiently detect AD pathology but inadequately reflect the extent of cognitive impairment or disease heterogeneity.

View Article and Find Full Text PDF

Importance: Survivors of critical illness often have ongoing issues that affect functioning, including driving ability.

Objective: To examine whether intensive care unit (ICU) delirium is independently associated with long-term changes in driving behaviors.

Design, Setting, And Participants: This multicenter, longitudinal cohort study included 151 survivors of critical illness residing within 200 miles of Nashville, Tennessee.

View Article and Find Full Text PDF

Importance: Higher intellectual abilities have been associated with lower mortality risk in several longitudinal cohort studies. However, these studies did not fully account for early life contextual factors or test whether the beneficial associations between higher neurocognitive functioning and mortality extend to children exposed to early adversity.

Objective: To explore how the associations of child neurocognition with mortality changed according to the patterns of adversity children experienced.

View Article and Find Full Text PDF

The purpose of this study was to investigate the efficacy and safety of add-on metformin treatment in persons with active epilepsy (a-PWE). This is a single-centric, double-blind, placebo-controlled trial randomised a-PWE (1:1) to receive either metformin (extended-release 500 mg) or matching placebo for 6 months along with background antiseizure medications. Primary outcome was percentage change in seizure frequency/month, and secondary outcomes were 50% responder rate, serum mTOR expression, and serum total antioxidant capacity (TAC), body composition analysis, quality of life (QOL), and safety assessment.

View Article and Find Full Text PDF